Non Hodgkin Lymphoma (NHL)

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +6 more
  • 8/12-Day Production of Car-T Cells
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Jul 1, 2022

Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) Trial in Zhengzhou, Hangzhou (CD19-UCART)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Non Hodgkin Lymphoma (NHL)
  • CD19-UCART
  • Zhengzhou, Henan, China
  • +1 more
Apr 2, 2022

Non Hodgkin Lymphoma (NHL), Diffuse Large B-cell Lymphoma (DLBCL) Trial in United States (rituximab, prednisone, Geriatric

Active, not recruiting
  • Non Hodgkin Lymphoma (NHL)
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Basking Ridge, New Jersey
  • +7 more
Mar 9, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Non-interventional, Long-term Follow-up of Subjects Who

Unknown status
  • Acute Myelogenous Leukemia (AML)
  • +3 more
  • non intervational
  • Haifa, Israel
    Rambam Medical Center
Nov 24, 2019

Non Hodgkin Lymphoma (NHL) Trial in Praha

Recruiting
  • Non Hodgkin Lymphoma (NHL)
    • Praha, Czechia
      Charles University General Hospital
    Jun 21, 2017